Hangzhou AllTest Biotech Co., Ltd is located in 550#，Yinhai Street, Baiyang District, Hangzhou Economic-Technological Development Area, the company registered capital of 15 million RMB. The company’s total construction area is about 3200 M2. The company holds strong ability of scientific research and innovative technology. AllTest Biotech leads the development frontier of biological technologies such as monoclonal antibody-colloidal gold and latex technique, gene engineering, compound antigen and immunoassay.
AllTest Biotech is thriving on design, development, manufacturing and sales of the lateral flow rapid IVD products and food safety test product. The product is broadly recognized in the international market for its rapid, convenience and accurateness. AllTest Biotech will strive to become the leader and pioneer in the diagnostic industry field of China and the world.
Alomone Labs, your partner in ion channel research, is a leading supplier of Ion Channel, GPCR and Neural Signaling tools. We specialize in the production of primary antibodies, small molecules and proteins and peptides used in basic science research. Alomone was established in 1989 and has become the most comprehensive source of ion channel research tools used by scientists worldwide. All of Alomone`s products undergo bioassay validation and are supplied in lyophilized powder format so that you can be confident about their biological activity and long shelf life.
Founded in 1993 and headquartered in Guangdong, China, DaAn Gene Co., Ltd is a global medical diagnostic company engaged in the discovery, development, manufacturing and marketing of a broad range of innovative products for clinical diagnosis, health management and other fields.
DaAn Gene has consistently committed to advance the world of health by improving medical discovery and diagnostics based on molecular technology.
On August 9, 2004, DaAn Gene was listed on the Shenzhen Stock Exchange. It currently owns more than 797 million shares and has a market value of over 32.9 billion.
DaAn has been in the molecular diagnostic industry for more than 20 years and is ISO13485 and GMP certified. DaAn’s product line contains over 100 NMPA and 50 CE marked products based on real-time PCR technology, molecular hybridization and sanger sequence, including real-time PCR diagnostic kits and instruments, automatic nucleic acid extraction, immunoassay kits, pathology products and so on, now serving customers in more than 140 countries through subsidiaries and strong distribution networks.
With the mission of "Decoding Genetic life, assuring human health", DaAn will continue to develop world-class quality products and provide reliable service!
ImmunoDiagnostics Limited (IMD) is a spin-off biotech company from The University of Hong Kong. The company is dedicated to biomarker discovery, assay development and in vitro diagnostics (IVD) of major chronic diseases, particularly on cardio-metabolic diseases and autoimmune diseases.
The company has established an integrated “biomarker/antigen-antibody-immunoassay” pipeline for the development of innovative diagnostic products. Firstly, new biomarkers are expressed in the form of recombinant proteins with different protein expression systems and are subsequently purified to a final purity of above 95% by procedures such as affinity purification, ion-exchange chromatography, size exclusion chromatography and gel infiltration. Secondly, by using high-quality recombinant proteins as antigens, antibodies are generated in the serum of host animals such as rabbits or mice after immunization and are further purified from the serum by performing both IgG- and antigen-based affinity purification; Lastly, highly specific antibodies are used for the development of a series of innovative semi- or fully automatic immunoassays with supreme sensitivity, specificity and efficiency, including immunoblotting assays, enzyme-linked immunosorbent assays (ELISAs), as well as immunoturbidimetry assays (ITAs), chemiluminescence assays (CLIAs), which can be directly applied in clinical diagnosis.
KYinno is dedicated to oncology drug discovery service and customized product development, with a focus on immuno-oncology and next-generation kinase inhibitor discovery.
Our service platforms include:
- Engineered custom cell line development
- Cell-based assay validation and compound screening
- Phage display library and hybridoma technology for antibody drug discovery
- Cancer cell panel compound profiling and biomarker discovery
Our products include:
- Engineered reporter cell lines
- Antibody and proteins with fully validated functions in reporter cell lines
Our team members have years of experience in the pharmaceutical and biotechnology industry in both China and U.S.